Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DuraStat
AddedFeb 15, 2024
UpdatedJun 18, 2026
DuraStat

DuraStat

Series B

DuraStat: Enhancing surgical efficiency with our innovative device for optimal, time-saving dural repairs.

HQ
Austin, TX, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

DuraStat is a pioneering company focused on enhancing surgical efficiency through its innovative dural repair device. The core mission is to provide safer, faster, and higher-quality dural repairs, addressing issues such as incidental durotomy and CSF leaks. The device features a needle and suture retained within a smooth, curved tip, allowing for optimal needle placement and suture passage with a simple button press. This design consolidates steps, saves time, and eliminates the need for supination, making it ideal for surgeries with limited access.

DuraStat has made significant strides in the medical field by offering a solution that improves the quality and speed of dural repairs. The device's ability to facilitate sutured repairs, which are known to prevent persistent CSF leaks, has positioned it as a gold standard in surgical procedures. The company's impact is evident in its contribution to safer surgical outcomes and increased efficiency in operating rooms.

DuraStat - Similar Companies

Surgimatix logo

Surgimatix

surgimatix.com

Opus KSD logo

Opus KSD

subq-it.com

Surgrx logo

Surgrx

Suture Concepts logo

Suture Concepts

Dualflo logo

Dualflo

Suturegard Medical logo

Suturegard Medical

suturegard.com

Seguro Surgical logo

Seguro Surgical

EndoEvolution logo

EndoEvolution

SteriDev logo

SteriDev

steridev.com

Revmedica logo

Revmedica

revmedica.com

Hubly Surgical logo

Hubly Surgical

Edge Surgical logo

Edge Surgical

edgesurgical.com

BondTrue logo

BondTrue

bondtrue.com

Agile EndoSurgery logo

Agile EndoSurgery

Incisive Surgical logo

Incisive Surgical

insorb.com

DuraStat - Quick Facts

Who are DuraStat's competitors?

Companies similar to DuraStat include Surgimatix, Opus KSD, Surgrx and Suture Concepts.

When was DuraStat founded?

DuraStat was founded in 2015.

Where is DuraStat's headquarters located?

DuraStat's headquarters is located in Austin, TX, US.

When was DuraStat's last funding round?

DuraStat's most recent funding round was for $5M (USD) in April 2022.

How much has DuraStat raised to-date?

As of Apr 29, 2022, DuraStat has raised a total of $9.5M (USD).

How many employees does DuraStat have?

DuraStat has 15 employees as of Feb 5, 2024.

DuraStat - Classification

Industry
  • Hardware
  • Hospitals
Ownership
  • Private
Technology
  • Medical Devices
Geographic Exposure
  • Global
Revenue
  • Transactional
Main Product
  • Surgical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified